| GlaxoSmithKline AG - Priorix-Tetra, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 58158 | | 01 | | Priorix-Tetra | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | J07BD54 | | Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated | | 02.08.2009 | | |
| | Composition | | Vaccinum attenuatum: virus morbilli vivus (Stamm: Schwarz) min. 10^3 U., virus parotitis vivus (Stamm: RIT 4385) min.10^4.4 U., virus rubella vivus (Stamm: Wistar RA 27/3) min.10^3 U., virus varicellae vivus (Stamm: OKA) min.10^3.3 U., lactosum, sorbitolum 14 mg, mannitolum, aminoacida cum phenylalaninum 0.583 mg, residui: neomycini sulfas, pro praeparatione.
Solvens: aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. | | Packungsbestandteile | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose | additional_information |
|---|
| | 10 U | Vaccinum attenuatum | | | 10 U | | | | 10 U | | | | 10 U | |
| | | | | Inactive agents | | additional_information |
|---|
| Aminoacida | | | | | | | | Mannitol | | | | | | residui | | Sorbitol | | |
| |
| Lyophilisate and solvent | | | | | | | | Active Agent | Dose | additional_information |
|---|
| | 10 U | Vaccinum attenuatum | | | 10 U | | | | 10 U | | | | 10 U | |
| | | | | Inactive agents | Dose | additional_information |
|---|
| | 0.583 mg | | | | | | | Mannitol | | | | Neomycin Sulfate | | residui | | Sorbitol | 14 mg | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 66.69 | 88.95 | B | SL | No |
|
|
